← Leaderboards
C Michael Hart
Emory University
$6,695,798
Attributed
$9,817,309
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $913.4K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,817,309 · 7
VA$0 · 3
By mechanism
R01$5,554,527 · 4
T32$3,879,124 · 2
R21$383,658 · 1
I01$0 · 3
Top collaborators
- Roy L Sutliff8 shared
- Lou Ann S. Brown5 shared
- David Marshall Guidot5 shared
- Jeanie Park1 shared
Most similar at Emory University
Same institution · by research overlap
- Roy L Sutliff$3,270,141
- Rebecca A Gary$2,065,167
- Aaron Wayne Trammell$534,600
- Samantha M. Yeligar$2,947,397
- Sherry Adesina$61,144
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMorbidity - Disease RatePathogenesisIn VitroSmooth Muscle MyocytesPathway InteractionsLungLoss Of FunctionLigandsNovel StrategiesMolecularBlood VesselsPhenotypePpar GammaMediatingAttenuatedNadph OxidaseRegulationPulmonary Artery StructurePulmonary HypertensionCell ProliferationMetabolicVascular RemodelingHypoxia
Grant awards (41)
Targeting mitoNEET in pulmonary hypertension$596,809
R01 · FY2025 · HL · contact PI
Atlanta VA Summer Research Program$0
I01 · FY2025 · VA · contact PI
Mitophagy in pulmonary hypertension: Novel roles of PTEN-Induced Kinase-1 in the pathobiology of pulmonary artery smooth muscle cell proliferation and mitochondrial dysfunction$0
I01 · FY2023 · VA · contact PI
The Emory Training Program in Lung Health$550,236
T32 · FY2022 · HL
Mitophagy in pulmonary hypertension: Novel roles of PTEN-Induced Kinase-1 in the pathobiology of pulmonary artery smooth muscle cell proliferation and mitochondrial dysfunction$0
I01 · FY2022 · VA · contact PI
The Emory Training Program in Lung Health$609,575
T32 · FY2021 · HL
Mitophagy in pulmonary hypertension: Novel roles of PTEN-Induced Kinase-1 in the pathobiology of pulmonary artery smooth muscle cell proliferation and mitochondrial dysfunction$0
I01 · FY2021 · VA · contact PI
The Emory Training Program in Lung Health$600,030
T32 · FY2020 · HL
Mitophagy in pulmonary hypertension: Novel roles of PTEN-Induced Kinase-1 in the pathobiology of pulmonary artery smooth muscle cell proliferation and mitochondrial dysfunction$0
I01 · FY2020 · VA · contact PI
The Emory Training Program in Lung Health$559,863
T32 · FY2019 · HL
Mitophagy in pulmonary hypertension: Novel roles of PTEN-Induced Kinase-1 in the pathobiology of pulmonary artery smooth muscle cell proliferation and mitochondrial dysfunction$0
I01 · FY2019 · VA · contact PI
The Emory Training Program in Lung Health$467,473
T32 · FY2018 · HL
PPAR gamma and Nox4 in pulmonary hypertension$320,500
R01 · FY2018 · HL · contact PI
PPAR gamma and Nox4 in pulmonary hypertension$320,500
R01 · FY2017 · HL · contact PI
PPAR gamma and Nox4 in pulmonary hypertension$320,500
R01 · FY2016 · HL · contact PI
Mechanisms and Consequences of Reduced PPAR gamma in Pulmonary Hypertension$0
I01 · FY2016 · VA · contact PI
PPAR gamma and Nox4 in pulmonary hypertension$309,220
R01 · FY2015 · HL · contact PI
Mechanisms and Consequences of Reduced PPAR gamma in Pulmonary Hypertension$0
I01 · FY2015 · VA · contact PI
PPAR gamma and Nox4 in pulmonary hypertension$314,200
R01 · FY2014 · HL · contact PI
Mechanisms and Consequences of Reduced PPAR gamma in Pulmonary Hypertension$0
I01 · FY2014 · VA · contact PI
PPAR gamma and Nox4 in pulmonary hypertension$305,288
R01 · FY2013 · HL · contact PI
Training Program in Academic Pulmonary Medicine$112,782
T32 · FY2013 · HL · contact PI
Mechanisms and Consequences of Reduced PPAR gamma in Pulmonary Hypertension$0
I01 · FY2013 · VA · contact PI
PPAR gamma and Nox4 in pulmonary hypertension$324,424
R01 · FY2012 · HL · contact PI
PPAR gamma regulates vascular endothelial reactive species production in diabetes$268,878
R01 · FY2012 · DK · contact PI
Training Program in Academic Pulmonary Medicine$187,871
T32 · FY2012 · HL · contact PI
PPAR gamma and Nox4 in pulmonary hypertension$312,154
R01 · FY2011 · HL · contact PI
PPAR gamma regulates vascular endothelial reactive species production in diabetes$304,065
R01 · FY2011 · DK · contact PI
Training Program in Academic Pulmonary Medicine$297,176
T32 · FY2011 · HL · contact PI
PPAR gamma regulates vascular endothelial reactive species production in diabetes$340,834
R01 · FY2010 · DK · contact PI
Training Program in Academic Pulmonary Medicine$215,255
T32 · FY2010 · HL · contact PI
PPAR gamma regulates vascular endothelial reactive species production in diabetes$325,125
R01 · FY2009 · DK · contact PI
Training Program in Academic Pulmonary Medicine$278,863
T32 · FY2009 · HL · contact PI
PPAR gamma regulates vascular endothelial reactive species production in diabetes$33,725
R01 · FY2009 · DK · contact PI
PPAR gamma regulates vascular endothelial reactive species production in diabetes$307,105
R01 · FY2008 · DK · contact PI
PPAR gamma and alveolar macrophage function during chronic alcohol ingestion$176,418
R21 · FY2007 · AA · contact PI
PPAR gamma/alveolar macrophage function and alcohol$207,240
R21 · FY2006 · AA · contact PI
Fatty Acids Alter Endothelial Nitric Oxide Production$212,800
R01 · FY2004 · DK
Fatty Acids Alter Endothelial Nitric Oxide Production$212,800
R01 · FY2003 · DK
Fatty Acids Alter Endothelial Nitric Oxide Production$212,800
R01 · FY2002 · DK
Fatty Acids Alter Endothelial Nitric Oxide Production$212,800
R01 · FY2001 · DK